LON:NGG^J17 | NEXTGEN GROUP (NGG) Pharmaceuticals & Biotechnology - Chart

17th Jan '11 by flyingswan

4 comments 2996 reads

Nextgen Group (LON:NGG) Chart Breakout and Trading above 200 Day Moving Average:

Back Ground Highlights

· New business plan written to redefine the product options and align these with market access

· Core focus remains on biomarker discovery, assay development and biomarker qualification

· Simplification of product mix to focus resource on custom biomarker projects and on developing therapeutically relevant 'assay panels' for biomarker discovery and qualification

· New product lines identified for development; Plasma and Cerebrospinal Fluid assay panels for biomarker discovery and qualification

· Cerebrospinal Fluid assay panel (19 protein) launched in May 2010 targeting the Central Nervous System market segment and in particular Alzheimer's disease

· Plasma panel development initiated with a view to focusing on the Oncology market segment

· Multiple biomarker discovery and assay development projects delivered

· Sales in the period were $708,831 (2009: $807,769), excluding discontinued operations

· Funding of $2.4 million received in the period, $1.3 million through share issues and $1.1 million from convertible loans

The Chart appears to have broken out of the long term down trend and a recovery is under way. IMHO

Share price now trading above the 200 day moving average.

Unlock with Email

Unlock with Google

Already have an account?
Login here

flyingswan

3rd Feb '11

NextGen Group enter into an agreement with Takeda Pharmaceutical Company Limited: Nextgen Group (LON:NGG)

See link
http://www.nextgensciences.com/pdf/NextGen%20Takeda%20press%20release.pdf

Looks like a great deal for nextgen, believe off the back of this, it's going north. What do you think?

9th Feb '11

Nextgen Group (LON:NGG) over 200% rise today has triggered some news comment:

...The huge rise in the share price seems to be due to the re-rating that is taking place across the biotech sector on AIM, with investors looking to top up on in a sector that has traditionally disappointed for the last few years, with shares trading at tiny amounts suddenly appearing as huge bargains to private investors keen to profit from the wave of excitement surrounding companies such as Angel Biotechnology Holdings (ABH), Physiomics (PYC), Sareum (SAR) and now NextGen Group (NGG)...

http://www.growthcompany.co.uk/news/1600483/nextgen-thunders-forward.thtml

16th Feb '11

NextGen Group - SPECULATIVE BUY
16/02/2011 Ben Jaglom

Biotech minnow NextGen Group (NGG) is hoping to grow profits through its specialist services.

The AIM-quoted company, which has its operational hub in the US and a sales and administration team in the UK, specialises in biomarker discovery and the development of assays. Its divisions include assayexpress, a service for developing protein biomarker assays, testingexpress, a means of testing and validating samples in a biomarket study and discoveryexpress, a suite of methods and platforms for biomarker and drug target discovery.

Growth Company Investor spoke to Klaus Rosenau, the German CEO and veteran of a number of German IT concerns. Enthusing that he has 'a lot of contacts' within the investment industry Rosenau remarked on the recent excitement in the AIM biotech sector. 'Biotech is taking off at the moment - this is because those analysing the market as a whole realise that now is probably the best time to jump on the train'...

http://www.growthcompany.co.uk/recommendations/1602593/nextgen-group.thtml

£NGG

20th Feb '11

I would be pleased if you could take a look at Nextgen Group (LON:NGG) chart:

6a6u2ht

The chart appears to be breaking out quite quickly at the moment, with high volume of trades. This could also be that only 14% of the shares are in Free Float the other 86% are held by Family trust so in safe hands.

I was wondering how high you thought the breakout may go. I have used the Max chart here, so you can see the full picture. Do you think it will go back up to 5p as at the beginning of the chart?

Nextgen Group (LON:NGG)

NEXTGEN GROUP (NGG) Pharmaceuticals & Biotechnology - Chart

Unlock the rest of this article with a 14 day trial

About the Author

Flyingswan

4 comments

Unlock the metrics for all these stocks and more...

Unlock the metrics for all these stocks and more...